{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T09:40:23Z","timestamp":1738662023903,"version":"3.35.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pharma.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T18:34:27Z","timestamp":1724524467000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application progress of nanomaterials in the treatment of prostate cancer"],"prefix":"10.1016","volume":"83","author":[{"given":"Xuewu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longtu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyu","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.08.009_bib0795","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pharma.2024.08.009_bib0800","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharma.2024.08.009_bib0805","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pharma.2024.08.009_bib0810","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMe1103829","article-title":"Risk-based management of prostate cancer","volume":"365","author":"D\u2019Amico","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib0815","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMclde0805491","article-title":"Clinical decisions. Management of prostate cancer","volume":"359","author":"Schr\u00f6der","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib0820","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cncr.22544","article-title":"Radical prostatectomy for clinical stage T3a disease","volume":"109","author":"Freedland","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.pharma.2024.08.009_bib0825","doi-asserted-by":"crossref","first-page":"g1502","DOI":"10.1136\/bmj.g1502","article-title":"Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes","volume":"348","author":"Sooriakumaran","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.pharma.2024.08.009_bib0830","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/cancers14040967","article-title":"Prospect of prostate cancer treatment: armed CAR-T or combination therapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharma.2024.08.009_bib0835","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1464-410X.2010.09334.x","article-title":"Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology","volume":"106","author":"Droz","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.pharma.2024.08.009_bib0840","doi-asserted-by":"crossref","first-page":"1126752","DOI":"10.3389\/fonc.2023.1126752","article-title":"Progression in immunotherapy for advanced prostate cancer","volume":"13","author":"Liang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0845","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1038\/srep07713","article-title":"Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer","volume":"5","author":"Lei","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2024.08.009_bib0850","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery versus radiotherapy for clinically-localized prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0855","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0860","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0749-2081(92)90027-Z","article-title":"Chemotherapy-induced myelosuppression","volume":"8","author":"Maxwell","year":"1992","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.pharma.2024.08.009_bib0865","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","article-title":"Chemotherapy-induced alopecia","volume":"67","author":"Chon","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0870","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00520-018-4464-y","article-title":"ASCO, NCCN, MASCC\/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients","volume":"27","author":"Razvi","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.pharma.2024.08.009_bib0875","doi-asserted-by":"crossref","first-page":"114743","DOI":"10.1016\/j.bcp.2021.114743","article-title":"Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics","volume":"192","author":"Arinno","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0880","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.3390\/ijms22168733","article-title":"Preclinical and clinical evidence of therapeutic agents for paclitaxel-induced peripheral neuropathy","volume":"22","author":"Kawashiri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2024.08.009_bib0885","doi-asserted-by":"crossref","first-page":"120545","DOI":"10.1016\/j.biomaterials.2020.120545","article-title":"Intelligent MoS(2)-CuO heterostructures with multiplexed imaging and remarkably enhanced antitumor efficacy via synergetic photothermal therapy\/chemodynamic therapy\/immunotherapy","volume":"268","author":"Jiang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib0890","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0895","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.2147\/IJN.S212184","article-title":"Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic\/HIFU therapy","volume":"14","author":"Li","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib0900","first-page":"57","article-title":"Red blood cell-mimic nanocatalyst triggering radical storm to augment cancer immunotherapy","volume":"14","author":"Li","year":"2022","journal-title":"Nanomicro Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib0905","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2021.06.003","article-title":"Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer","volume":"517","author":"Nesbitt","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib0910","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2019.04.003","article-title":"Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal","volume":"139","author":"Logan","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2024.08.009_bib0915","first-page":"3767","article-title":"Case report: a non-small cell lung cancer patient treated with GcMAF, sonodynamic therapy and tumor treating fields","volume":"36","author":"Inui","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib0920","doi-asserted-by":"crossref","first-page":"e202210415","DOI":"10.1002\/anie.202210415","article-title":"A forward vision for chemodynamic therapy: issues and opportunities","volume":"62","author":"Zhao","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pharma.2024.08.009_bib0925","doi-asserted-by":"crossref","first-page":"e2200379","DOI":"10.1002\/smtd.202200379","article-title":"Near-infrared-II light induced mild hyperthermia activate cisplatin-artemisinin nanoparticle for enhanced chemo\/chemodynamic therapy and immunotherapy","volume":"6","author":"Xiong","year":"2022","journal-title":"Small Meth"},{"key":"10.1016\/j.pharma.2024.08.009_bib0930","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.biomaterials.2008.04.016","article-title":"Universal cell labelling with anionic magnetic nanoparticles","volume":"29","author":"Wilhelm","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib0935","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biomaterials.2007.10.019","article-title":"Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems","volume":"29","author":"Yang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib0940","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/bm060474b","article-title":"Physicochemical and transfection properties of cationic Hydroxyethylcellulose\/DNA nanoparticles","volume":"7","author":"Fayazpour","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.pharma.2024.08.009_bib0945","doi-asserted-by":"crossref","first-page":"1001994","DOI":"10.3389\/fbioe.2022.1001994","article-title":"PPy@Fe(3)O(4) nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-\u03baB signaling pathway and promoting ferroptosis","volume":"10","author":"Yu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0950","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ultrasmedbio.2015.09.004","article-title":"Non-invasive measurement of thermal diffusivity using high-intensity focused ultrasound and through-transmission ultrasonic imaging","volume":"42","author":"Yeshurun","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0955","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cej.2018.01.060","article-title":"Nanoparticle-assisted ultrasound: a special focus on sonodynamic therapy against cancer","volume":"340","author":"Canavese","year":"2018","journal-title":"Chem Eng J"},{"key":"10.1016\/j.pharma.2024.08.009_bib0960","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.7150\/thno.68996","article-title":"pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal\/chemodynamic therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.pharma.2024.08.009_bib0965","doi-asserted-by":"crossref","first-page":"e1802244","DOI":"10.1002\/adma.201802244","article-title":"Emerging strategies of nanomaterial-mediated tumor radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.pharma.2024.08.009_bib0970","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib0975","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharma.2024.08.009_bib0980","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pharma.2024.08.009_bib0985","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharma.2024.08.009_bib0990","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharma.2024.08.009_bib0995","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1000","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/jpm11050330","article-title":"The quandary of DNA-based treatment assessment in de novo metastatic prostate cancer in the era of precision oncology","volume":"11","author":"Nakken","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41422-018-0089-4","article-title":"Elimination of CD4(low)HLA-G(+) T cells overcomes castration-resistance in prostate cancer therapy","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","article-title":"Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study","volume":"15","author":"Nam","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1020","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.19.01595","article-title":"Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy","volume":"37","author":"VanderWeele","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1025","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharma.2024.08.009_bib1030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharma.2024.08.009_bib1035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2024.08.009_bib1040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41391-021-00470-w","article-title":"Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial","volume":"25","author":"Kaushik","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.pharma.2024.08.009_bib1045","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/IJN.S44393","article-title":"Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration","volume":"8","author":"Gu","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1039\/D0BM01815E","article-title":"Responsive hyaluronic acid-gold cluster hybrid nanogel theranostic systems","volume":"9","author":"Lin","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.pharma.2024.08.009_bib1055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1107\/S2052252517017912","article-title":"Three-dimensional ultrastructural imaging reveals the nanoscale architecture of mammalian cells","volume":"5","author":"Yao","year":"2018","journal-title":"IUCrJ"},{"key":"10.1016\/j.pharma.2024.08.009_bib1060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.biotechadv.2013.10.013","article-title":"Nanotechnology-based intelligent drug design for cancer metastasis treatment","volume":"32","author":"Gao","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.pharma.2024.08.009_bib1065","doi-asserted-by":"crossref","first-page":"e1801778","DOI":"10.1002\/adma.201801778","article-title":"Organic semiconducting agents for deep-tissue molecular imaging: second near-infrared fluorescence, self-luminescence, and photoacoustics","volume":"30","author":"Miao","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.pharma.2024.08.009_bib1070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.biotechadv.2008.05.007","article-title":"Biosensor technology: technology push versus market pull","volume":"26","author":"Luong","year":"2008","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.pharma.2024.08.009_bib1075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/anie.200704392","article-title":"Au-Fe3O4 dumbbell nanoparticles as dual-functional probes","volume":"47","author":"Xu","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pharma.2024.08.009_bib1080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fncel.2017.00083","article-title":"Superparamagnetic iron oxide nanoparticle-mediated forces enhance the migration of schwann cells across the astrocyte-Schwann cell boundary in vitro","volume":"11","author":"Huang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharma.2024.08.009_bib1085","doi-asserted-by":"crossref","first-page":"6202876","DOI":"10.1155\/2018\/6202876","article-title":"A novel bimodal imaging agent targeting HER2 molecule of breast cancer","volume":"2018","author":"Lv","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/bios12060360","article-title":"A size-controlled graphene oxide materials obtained by one-step electrochemical exfoliation of carbon fiber cloth for applications to in situ gold nanoparticle formation and electrochemical sensors \u2013 a preliminary study","volume":"12","author":"Chang","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.pharma.2024.08.009_bib1095","doi-asserted-by":"crossref","first-page":"592538","DOI":"10.3389\/fchem.2020.592538","article-title":"Preparation of electrochemical sensor based on zinc oxide nanoparticles for simultaneous determination of AA, DA, and UA","volume":"8","author":"Pan","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1039\/C2NR32040A","article-title":"Nanostructured carbon-metal oxide composite electrodes for supercapacitors: a review","volume":"5","author":"Zhi","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.pharma.2024.08.009_bib1105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1039\/C1CS15060J","article-title":"A review of electrode materials for electrochemical supercapacitors","volume":"41","author":"Wang","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.pharma.2024.08.009_bib1110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature08053","article-title":"Five-dimensional optical recording mediated by surface plasmons in gold nanorods","volume":"459","author":"Zijlstra","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2024.08.009_bib1115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jphotobiol.2017.07.020","article-title":"Polyethylene glycol modified ORMOSIL theranostic nanoparticles for triggered doxorubicin release and deep drug delivery into ovarian cancer spheroids","volume":"174","author":"Nagesetti","year":"2017","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/nano7070189","article-title":"Mesoporous silica nanoparticles as drug delivery vehicles in cancer","volume":"7","author":"Watermann","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib1125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1369-7021(11)70161-4","article-title":"Carbon materials for drug delivery & cancer therapy","volume":"14","author":"Liu","year":"2011","journal-title":"Mater Today"},{"key":"10.1016\/j.pharma.2024.08.009_bib1130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acsmaterialslett.1c00073","article-title":"Functionalized MoS2-based nanomaterials for cancer phototherapy and other biomedical applications","volume":"3","author":"Liu","year":"2021","journal-title":"ACS Mater Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1135","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib1140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/153303460500400604","article-title":"In vivo biodistribution of dendrimers and dendrimer nanocomposites\u00a0\u2013\u00a0implications for cancer imaging and therapy","volume":"4","author":"Khan","year":"2005","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.pharma.2024.08.009_bib1145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2018.08.043","article-title":"Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems","volume":"288","author":"Dianat-Moghadam","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2024.08.009_bib1150","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3390\/nano11092328","article-title":"Novel contact lenses embedded with drug-loaded zwitterionic nanogels for extended ophthalmic drug delivery","volume":"11","author":"Wang","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.pharma.2024.08.009_bib1155","first-page":"4965","article-title":"The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particles","volume":"9","author":"Wang","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1160","doi-asserted-by":"crossref","first-page":"6854710","DOI":"10.1155\/2019\/6854710","article-title":"Biological characteristics and carrier functions of pegylated manganese zinc ferrite nanoparticles","volume":"2019","author":"Guo","year":"2019","journal-title":"J Nanomater"},{"key":"10.1016\/j.pharma.2024.08.009_bib1165","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acsnano.7b08616","article-title":"Enhancing both biodegradability and efficacy of semiconducting polymer nanoparticles for photoacoustic imaging and photothermal therapy","volume":"12","author":"Lyu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.pharma.2024.08.009_bib1170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2019.05.018","article-title":"Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?","volume":"305","author":"Tang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2024.08.009_bib1175","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/acsabm.4c00004","article-title":"Carbon dots: synthesis, characterizations, and recent advancements in biomedical, optoelectronics, sensing, and catalysis applications","volume":"7","author":"Lamba","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.pharma.2024.08.009_bib1180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02656736.2014.992484","article-title":"Treating cancer with sonodynamic therapy: a review","volume":"31","author":"Costley","year":"2015","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.pharma.2024.08.009_bib1185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.drudis.2014.01.010","article-title":"Recent progress in development of new sonosensitizers for sonodynamic cancer therapy","volume":"19","author":"Chen","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharma.2024.08.009_bib1190","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.cclet.2021.12.096","article-title":"Tumor microenvironment-responsive MnSiO3-Pt@ BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy","volume":"33","author":"Jiang","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1195","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/jacs.6b11846","article-title":"Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy","volume":"139","author":"Huang","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharma.2024.08.009_bib1200","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/ncomms5596","article-title":"A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation","volume":"5","author":"Ge","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharma.2024.08.009_bib1205","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/s41467-019-11098-9","article-title":"Molecular bilayer graphene","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharma.2024.08.009_bib1210","doi-asserted-by":"crossref","first-page":"110393","DOI":"10.1016\/j.matdes.2022.110393","article-title":"Ultrasonic effects on gas tungsten arc based wire additive manufacturing of aluminum matrix nanocomposite","volume":"214","author":"Wang","year":"2022","journal-title":"Mater Des"},{"key":"10.1016\/j.pharma.2024.08.009_bib1215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12951-021-00822-7","article-title":"A non-invasive nanoparticles for multimodal imaging of ischemic myocardium in rats","volume":"19","author":"Chen","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1220","first-page":"474","article-title":"Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment","volume":"59","author":"Bednarz","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharma.2024.08.009_bib1225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1118\/1.3668316","article-title":"Attenuation, scattering, and absorption of ultrasound in the skull bone","volume":"39","author":"Pinton","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.pharma.2024.08.009_bib1230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/ol.2021.12620","article-title":"Research progress of berberine mediated photodynamic therapy","volume":"21","author":"An","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1235","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1021\/la503929c","article-title":"Polymeric microbubbles as delivery vehicles for sensitizers in sonodynamic therapy","volume":"30","author":"McEwan","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.pharma.2024.08.009_bib1240","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.ultrasmedbio.2023.06.011","article-title":"Pulsed sonodynamic therapy of melanoma cancer cells using nanoparticles of and mesoporous platinum","volume":"49","author":"Zahraie","year":"2023","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1245","doi-asserted-by":"crossref","first-page":"756489","DOI":"10.3389\/fonc.2022.756489","article-title":"Cetuximab combined with sonodynamic therapy achieves dual-modal image monitoring for the treatment of EGFR-sensitive non-small-cell lung cancer","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1250","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s12274-020-2992-5","article-title":"Recent advances in nanomaterials for sonodynamic therapy","volume":"13","author":"Xu","year":"2020","journal-title":"Nano Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1255","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1260","first-page":"5451","article-title":"Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery","volume":"55","author":"Netti","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1265","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Zhou","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.pharma.2024.08.009_bib1270","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/cancers11111783","article-title":"Targeting integrins in cancer nanomedicine: applications in cancer diagnosis and therapy","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.pharma.2024.08.009_bib1275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nano.2015.10.020","article-title":"Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance","volume":"12","author":"Chen","year":"2016","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biomaterials.2016.06.063","article-title":"Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies","volume":"103","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib1285","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1111\/jcmm.13811","article-title":"Theranostic nanosensitizers for highly efficient MR\/fluorescence imaging-guided sonodynamic therapy of gliomas","volume":"22","author":"Liu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1290","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.2147\/IJN.S361648","article-title":"Low intensity focused ultrasound ignited \u201cdeep-penetration nanobomb\u201d (DPNB) for tetramodal imaging guided hypoxia-tolerant sonodynamic therapy against hypoxic tumors","volume":"17","author":"Luo","year":"2022","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biomaterials.2016.08.049","article-title":"Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery","volume":"108","author":"Min","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib1300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.acra.2014.09.015","article-title":"Automated breast segmentation of fat and water MR images using dynamic programming","volume":"22","author":"Rosado-Toro","year":"2015","journal-title":"Acad Radiol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s43055-024-01194-2","article-title":"Can non-contrast magnetic resonance imaging replace contrast-enhanced computerized tomography in the local staging of pediatric renal tumors?","volume":"55","author":"Romeih","year":"2024","journal-title":"Egypt J Radiol Nucl Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1310","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1002\/smll.201500997","article-title":"Preoperative detection and intraoperative visualization of brain tumors for more precise surgery: a new dual-modality MRI and NIR nanoprobe","volume":"11","author":"Li","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.pharma.2024.08.009_bib1315","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.2147\/IJN.S110488","article-title":"Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins","volume":"11","author":"Perepelyuk","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1320","doi-asserted-by":"crossref","first-page":"805205","DOI":"10.3389\/fchem.2021.805205","article-title":"Fluorescent copper nanomaterials for sensing NO(2) (-) and temperature","volume":"9","author":"Wang","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1325","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1039\/C9TB01597C","article-title":"Polyphenol-based nanoplatform for MRI\/PET dual-modality imaging guided effective combination chemotherapy","volume":"7","author":"Wang","year":"2019","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.pharma.2024.08.009_bib1330","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-020-15591-4","article-title":"An open source and reduce expenditure ROS generation strategy for chemodynamic\/photodynamic synergistic therapy","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharma.2024.08.009_bib1335","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.nantod.2021.101161","article-title":"Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles","volume":"39","author":"Gao","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.pharma.2024.08.009_bib1340","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1345","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/anie.201510031","article-title":"Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction","volume":"55","author":"Zhang","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pharma.2024.08.009_bib1350","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/antiox11010111","article-title":"Selenomethionine ameliorates cognitive impairment, decreases hippocampal oxidative stress and attenuates dysbiosis in D-Galactose-treated mice","volume":"11","author":"Gao","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharma.2024.08.009_bib1355","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","article-title":"Hydroperoxide metabolism in mammalian organs","volume":"59","author":"Chance","year":"1979","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharma.2024.08.009_bib1360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/tbmb.718540875","article-title":"Plant peroxisomes, reactive oxygen metabolism and nitric oxide","volume":"55","author":"del R\u00edo","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharma.2024.08.009_bib1365","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41467-017-00424-8","article-title":"Tumor-selective catalytic nanomedicine by nanocatalyst delivery","volume":"8","author":"Huo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharma.2024.08.009_bib1370","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201701683","article-title":"Antiferromagnetic pyrite as the tumor microenvironment-mediated nanoplatform for self-enhanced tumor imaging and therapy","volume":"29","author":"Tang","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.pharma.2024.08.009_bib1375","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s40820-020-00516-z","article-title":"Boosting chemodynamic therapy by the synergistic effect of co-catalyze and photothermal effect triggered by the second near-infrared light","volume":"12","author":"Zhang","year":"2020","journal-title":"Nano-micro Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1380","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1021\/acsnano.8b01893","article-title":"All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.pharma.2024.08.009_bib1385","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1021\/jacs.9b03457","article-title":"Synthesis of copper peroxide nanodots for H(2)O(2) self-supplying chemodynamic therapy","volume":"141","author":"Lin","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharma.2024.08.009_bib1390","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jacs.8b08714","article-title":"Self-assembled copper-amino acid nanoparticles for in situ glutathione \u201cAND\u201d H(2)O(2) sequentially triggered chemodynamic therapy","volume":"141","author":"Ma","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharma.2024.08.009_bib1395","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1002\/anie.201712027","article-title":"Simultaneous Fenton-like ion delivery and glutathione depletion by MnO(2) -based nanoagent to enhance chemodynamic therapy","volume":"57","author":"Lin","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pharma.2024.08.009_bib1400","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3390\/nano11112902","article-title":"Exploiting the potential of supported magnetic nanomaterials as Fenton-like catalysts for environmental applications","volume":"11","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.pharma.2024.08.009_bib1405","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/pharmaceutics10040282","article-title":"A systematic review and critical analysis of the role of graphene-based nanomaterialsin cancer theranostics","volume":"10","author":"Viseu","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.08.009_bib1410","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2015.01.001","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","volume":"21","author":"Xu","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharma.2024.08.009_bib1415","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2014.05.029","article-title":"Sustained-release from nanocarriers: a review","volume":"193","author":"Natarajan","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2024.08.009_bib1420","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","article-title":"A review on nano-based drug delivery system for cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nano-micro Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1425","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C9TB02470K","article-title":"Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications","volume":"8","author":"Yuba","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.pharma.2024.08.009_bib1430","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.08.009_bib1435","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1440","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2012.03.007","article-title":"Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge","volume":"320","author":"Hung","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharma.2024.08.009_bib1445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bjc.6603559","article-title":"Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells","volume":"96","author":"Nakano","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharma.2024.08.009_bib1450","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drup.2009.07.001","article-title":"Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib","volume":"12","author":"Broxterman","year":"2009","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.pharma.2024.08.009_bib1455","first-page":"2473","article-title":"Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs","volume":"7","author":"Li","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.pharma.2024.08.009_bib1465","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1470","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","article-title":"Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies","volume":"320","author":"Marques","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2024.08.009_bib1475","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/acs.bioconjchem.1c00192","article-title":"Stable and highly efficient antibody-nanoparticles conjugation","volume":"32","author":"Maddahfar","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1480","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ab.2012.11.012","article-title":"Label-free electrochemical immunosensor for prostate-specific antigen based on silver hybridized mesoporous silica nanoparticles","volume":"434","author":"Wang","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1485","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/cgt.2016.42","article-title":"Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA\/LSPR as a novel approach for the identification of prostate anomalies","volume":"23","author":"Jazayeri","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharma.2024.08.009_bib1490","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ab.2017.08.001","article-title":"Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor","volume":"536","author":"Pal","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharma.2024.08.009_bib1495","doi-asserted-by":"crossref","first-page":"e97220","DOI":"10.1371\/journal.pone.0097220","article-title":"Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging","volume":"9","author":"Bates","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2024.08.009_bib1500","doi-asserted-by":"crossref","first-page":"112729","DOI":"10.1016\/j.bios.2020.112729","article-title":"A novel chemiluminescence imaging immunosensor for prostate specific antigen detection based on a multiple signal amplification strategy","volume":"171","author":"Zhao","year":"2021","journal-title":"Biosensors Bioelectron"},{"key":"10.1016\/j.pharma.2024.08.009_bib1505","doi-asserted-by":"crossref","first-page":"97898","DOI":"10.1039\/C5RA19628K","article-title":"A fluorescence active gold nanorod\u2013quantum dot core\u2013satellite nanostructure for sub-attomolar tumor marker biosensing","volume":"5","author":"Wu","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.pharma.2024.08.009_bib1510","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijrobp.2021.04.032","article-title":"Prostate cancer targeted X-ray fluorescence imaging via gold nanoparticles functionalized with prostate-specific membrane antigen (PSMA)","volume":"111","author":"Hara","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pharma.2024.08.009_bib1515","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.03.071","article-title":"PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer","volume":"144","author":"Nagesh","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.pharma.2024.08.009_bib1520","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1021\/acsami.6b04286","article-title":"Site-directed conjugation of antibodies to apoferritin nanocarrier for targeted drug delivery to prostate cancer cells","volume":"8","author":"Dostalova","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.pharma.2024.08.009_bib1525","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1038\/s41598-018-26772-z","article-title":"Prostate-specific membrane antigen-targeted site-directed antibody-conjugated apoferritin nanovehicle favorably influences in vivo side effects of doxorubicin","volume":"8","author":"Dostalova","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2024.08.009_bib1530","first-page":"509","article-title":"Multiwalled carbon nanotubes as nanomaterial tool in the management of prostate cancer: a possible nanoformulation approach","volume":"12","author":"Murugesan","year":"2022","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.pharma.2024.08.009_bib1535","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","article-title":"Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells","volume":"64","author":"Farokhzad","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1540","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jare.2022.11.001","article-title":"Biomolecule-functionalized nanoformulations for prostate cancer theranostics","volume":"51","author":"Pranav","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.pharma.2024.08.009_bib1545","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.0601755103","article-title":"Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo","volume":"103","author":"Farokhzad","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2024.08.009_bib1550","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.2147\/IJN.S282107","article-title":"Aptamer-functionalized dendrimer delivery of plasmid-encoding lncRNA MEG3 enhances gene therapy in castration-resistant prostate cancer","volume":"15","author":"Tai","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pharma.2024.08.009_bib1555","doi-asserted-by":"crossref","first-page":"110181","DOI":"10.1016\/j.biopha.2020.110181","article-title":"Anti prostate cancer therapy: aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles","volume":"127","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2024.08.009_bib1560","doi-asserted-by":"crossref","first-page":"1805764","DOI":"10.1002\/adfm.201805764","article-title":"Functionalized holmium-doped hollow silica nanospheres for combined sonodynamic and hypoxia-activated therapy","volume":"29","author":"Wang","year":"2019","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.pharma.2024.08.009_bib1565","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jcis.2022.08.110","article-title":"Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy","volume":"628","author":"Xing","year":"2022","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.pharma.2024.08.009_bib1570","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1039\/D2TB01109C","article-title":"A Cu-based nanoplatform for near-infrared light amplified multi-mode prostate cancer specific therapy","volume":"10","author":"Xu","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.pharma.2024.08.009_bib1575","doi-asserted-by":"crossref","first-page":"133057","DOI":"10.1016\/j.cej.2021.133057","article-title":"Juglone-loaded metal-organic frameworks for H2O2 self-modulating enhancing chemodynamic therapy against prostate cancer","volume":"430","author":"Zhao","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.pharma.2024.08.009_bib1580","doi-asserted-by":"crossref","first-page":"120946","DOI":"10.1016\/j.biomaterials.2021.120946","article-title":"Urinary exosomes-based engineered nanovectors for homologously targeted chemo-chemodynamic prostate cancer therapy via abrogating EGFR\/AKT\/NF-kB\/IkB signaling","volume":"275","author":"Pan","year":"2021","journal-title":"Biomaterials"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T09:06:08Z","timestamp":1738659968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0003450924001317"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.08.009","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application progress of nanomaterials in the treatment of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}